139 related articles for article (PubMed ID: 28735518)
1. The possible prognostic role of histone deacetylase and transforming growth factor β/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study.
Sferra R; Pompili S; Festuccia C; Marampon F; Gravina GL; Ventura L; Di Cesare E; Cicchinelli S; Gaudio E; Vetuschi A
Eur J Histochem; 2017 May; 61(2):2732. PubMed ID: 28735518
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase 6 promotes growth of glioblastoma through inhibition of SMAD2 signaling.
Li S; Liu X; Chen X; Zhang L; Wang X
Tumour Biol; 2015 Dec; 36(12):9661-5. PubMed ID: 26150340
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylases 3 deletion restrains PM2.5-induced mice lung injury by regulating NF-κB and TGF-β/Smad2/3 signaling pathways.
Gu LZ; Sun H; Chen JH
Biomed Pharmacother; 2017 Jan; 85():756-762. PubMed ID: 27919737
[TBL] [Abstract][Full Text] [Related]
4. MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma.
Grzmil M; Morin P; Lino MM; Merlo A; Frank S; Wang Y; Moncayo G; Hemmings BA
Cancer Res; 2011 Mar; 71(6):2392-402. PubMed ID: 21406405
[TBL] [Abstract][Full Text] [Related]
5. HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells.
Marampon F; Megiorni F; Camero S; Crescioli C; McDowell HP; Sferra R; Vetuschi A; Pompili S; Ventura L; De Felice F; Tombolini V; Dominici C; Maggio R; Festuccia C; Gravina GL
Cancer Lett; 2017 Jul; 397():1-11. PubMed ID: 28342984
[TBL] [Abstract][Full Text] [Related]
6. Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma.
Jun F; Hong J; Liu Q; Guo Y; Liao Y; Huang J; Wen S; Shen L
Oncotarget; 2017 Feb; 8(9):14343-14358. PubMed ID: 27527869
[TBL] [Abstract][Full Text] [Related]
7. Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells.
Tritschler I; Gramatzki D; Capper D; Mittelbronn M; Meyermann R; Saharinen J; Wick W; Keski-Oja J; Weller M
Int J Cancer; 2009 Aug; 125(3):530-40. PubMed ID: 19431147
[TBL] [Abstract][Full Text] [Related]
8. Identification of the proliferative effect of Smad2 and 3 in the TGF β2/Smad signaling pathway using RNA interference in a glioma cell line.
Dong C; Mi R; Jin G; Zhou Y; Zhang J; Liu F
Mol Med Rep; 2015 Aug; 12(2):1824-8. PubMed ID: 25891822
[TBL] [Abstract][Full Text] [Related]
9. Differential Expression and Clinical Significance of Transforming Growth Factor-Beta Isoforms in GBM Tumors.
Roy LO; Poirier MB; Fortin D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642484
[TBL] [Abstract][Full Text] [Related]
10. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
[TBL] [Abstract][Full Text] [Related]
11. The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway.
Chen CW; Yang CH; Lin YH; Hou YC; Cheng TJ; Chang ST; Huang YH; Chung ST; Chio CC; Shan YS; Cheng HC; Chang WT
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917452
[TBL] [Abstract][Full Text] [Related]
12. [Expression of the proteins associated with transforming growth factor-beta/Smad signaling pathway in Peutz-Jeghers syndrome].
Wang YJ; Li LJ; Wu BP; Jiang B
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):774-6. PubMed ID: 20423848
[TBL] [Abstract][Full Text] [Related]
13. High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.
Bruna A; Darken RS; Rojo F; Ocaña A; Peñuelas S; Arias A; Paris R; Tortosa A; Mora J; Baselga J; Seoane J
Cancer Cell; 2007 Feb; 11(2):147-60. PubMed ID: 17292826
[TBL] [Abstract][Full Text] [Related]
14. Differing roles for TGF-β/Smad signaling in osteitis in chronic rhinosinusitis with and without nasal polyps.
Wang M; Ye T; Liang N; Huang Z; Cui S; Li Y; Huang Q; Zhou B
Am J Rhinol Allergy; 2015; 29(5):e152-9. PubMed ID: 26265084
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase 4 mediates SMAD family member 4 deacetylation and induces 5-fluorouracil resistance in breast cancer cells.
Yu SL; Lee DC; Son JW; Park CG; Lee HY; Kang J
Oncol Rep; 2013 Sep; 30(3):1293-300. PubMed ID: 23817620
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.
Kamato D; Burch ML; Piva TJ; Rezaei HB; Rostam MA; Xu S; Zheng W; Little PJ; Osman N
Cell Signal; 2013 Oct; 25(10):2017-24. PubMed ID: 23770288
[TBL] [Abstract][Full Text] [Related]
17. Anthocyanidins inhibit epithelial-mesenchymal transition through a TGFβ/Smad2 signaling pathway in glioblastoma cells.
Ouanouki A; Lamy S; Annabi B
Mol Carcinog; 2017 Mar; 56(3):1088-1099. PubMed ID: 27649384
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta pathway in human renal cell carcinoma and surrounding normal-appearing renal parenchyma.
Cardillo MR; Lazzereschi D; Gandini O; Di Silverio F; Colletta G
Anal Quant Cytol Histol; 2001 Apr; 23(2):109-17. PubMed ID: 11332076
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
Ding ZY; Jin GN; Wang W; Chen WX; Wu YH; Ai X; Chen L; Zhang WG; Liang HF; Laurence A; Zhang MZ; Datta PK; Zhang B; Chen XP
Hepatology; 2014 Nov; 60(5):1620-36. PubMed ID: 24954480
[TBL] [Abstract][Full Text] [Related]
20. Lack of activated Smad2 in transforming growth factor-beta signaling is an unfavorable prognostic factor in patients with esophageal squamous cell carcinoma.
Fukuchi M; Nakajima M; Miyazaki T; Masuda N; Osawa H; Manda R; Tsukada K; Kato H; Kuwano H
J Surg Oncol; 2006 Jul; 94(1):51-6. PubMed ID: 16788944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]